A s one of the facultatively intracellular bacteria, Salmonella enterica serovar Typhimurium (S. Typhimurium) replicates even in macrophages and induces their death-a key strategy of this virulent pathogen in evading the innate immune response. 1 The underlying mechanisms are well known but complex, because many pathways are involved, such as apoptosis, 2 necrosis, 3 pyroptosis 4 and autophagy. 5 In a recent issue of Nature Immunology, Robinson et al. reveal a novel pathway for killing macrophages during infection: type 1 interferon-(IFN-a and IFN-b) associated necroptosis. 6 To understand the novel pathway better, it is important to clarify the major differences between necrosis, apoptosis, autophagy, necroptosis and pyroptosis, and to recognize the various roles of IFN-a or IFN-b. The four pathways of programmed cell death (apoptosis, autophagy, necroptosis and pyroptosis) are compared in Table 1. For decades, necrosis and apoptosis have been the central paradigms for cell death. Apoptosis is programmed cell death characterized by activation of caspases in an extrinsic or intrinsic pathway and by the quiet elimination of unwanted cells without causing an inflammatory response. Apoptotic cells show cell membrane blebbing, cell shrinkage, chromatin condensation, ordered DNA fragmentation and formation of apoptotic bodies. On the other hand, necrosis represents accidental and uncontrolled passive cell death induced by, for example, severe heat shock, ischemia or mechanical rupture. Necrotic cells show an increase in cell volume, swelling of organelles, plasma membrane rupture and eventual release of intracellular contents with an inflammatory response as a consequence.
Despite the widespread use of apoptosis as a synonym for programmed cell death, accumulated evidence clearly shows that there are other types of programmed cell death as well. Non-apoptotic pathways include, at least, autophagy, necroptosis and pyroptosis.
The term autophagy was invented by Christian de Duve in 1963 to describe the ability of cells to digest their own cellular components. 7 Today, autophagy represents a self-digesting mechanism in which cytoplasmic components are engulfed by autophagosomes and degraded in lysosomes. 8 Autophagy has become increasingly recognized as a pathway of programmed cell death. However, autophagy can serve both pro-survival and pro-death functions. Autophagic cells are morphologically characterized by massive vacuolization due to the formation of many autophagic vesicles. As in apoptosis, autophagic cells can ultimately be removed by phagocytosis without causing inflammation.
The term necroptosis was proposed by Degterev et al. 9 to distinguish programmed necrosis of ischemic cells from accidental, uncontrolled necrosis, and from apoptosis. Cells undergoing necroptosis have morphological features of necrosis. However, necroptosis requires a unique signaling pathway associated with the activation of receptorinteracting protein (RIP) kinases. 10 RIP-1 and RIP-3 form a phosphorylation complex to activate necroptosis, 11 and RIP-1 kinase can be specifically inhibited by necrostatin-1. Necroptosis can be initiated by tumornecrosis factor a (TNF-a), Fas ligand and TNF-related apoptosis-inducing ligand, which are also well known to activate apoptosis. Inhibition of apoptotic caspases, particularly caspase-8, moves the cells towards necroptosis in response to TNF-a.
12,13 RIP-1-deficient mice display extensive apoptosis, dying soon after birth.
14 Necroptosis is now considered a major cell death pathway that is as important as apoptosis in regulating development and immunity. 15 However, the biological role of necroptosis during infection requires further study.
The term 'pyroptosis' was introduced by Cookson and Brennan to describe the atypical death of macrophages infected with S. Typhimurium. 16 Pyroptosis is also referred to as pro-inflammatory programmed cell death, because caspase-1 and IL-1b cause fever and inflammation. 4, 16 Pyroptotic cell death is mechanistically distinct from apoptosis and necroptosis, and may be classified as programmed necrosis.
Caspases are cysteine proteases that play essential roles in apoptosis, necrosis and inflammation. They can be roughly divided into apoptotic caspases and inflammatory caspases, of which the former includes apoptosis initiator caspases (-2, -8, -9 and -10) and executioner caspases (-3, -6 and -7). Activation of this cascade is a biochemical hallmark of apoptosis. The latter includes caspase-1, -4, -5, -13 and -14. In contrast to apoptosis, pyroptosis is triggered by caspase-1, which is activated in a large supramolecular complex termed the inflammasome. Caspase-1 is also an IL-1b-converting enzyme (ICE), hydrolyzing pro-IL-1b and pro-IL-18 into active IL-1b and IL-18. Unlike necroptosis, RIP-1 and -3 kinases are not involved in pytoptosis. Pyroptotic cells release not only intracellular contents, but also pro-inflammatory cytokines IL-1b and IL-18.
Type 1 IFNs play various roles in bacterial infections, e.g., protection from infections by extracellular bacteria 17 such as group B streptococci, pneumococci and Escherichia coli, and exacerbation of infections by intracellular bacteria such as Listeria monocytogenes.
18,19
The involvement of the IFN-a/IFN-b cascade in response to intracellular bacteria in phagocytes has been well established; however, the mechanism(s) is still largely unknown.
Robinson et al.'s paper adds IFN-a/IFN-bassociated necroptosis to the list of mechanisms that S. Typhimurium uses to kill macrophages. 6 By comparing the survival and bacterial burden in S. Typhimuriuminfected wild-type C57BL/6J mice, Ifnar1 macrophages have been convincingly excluded by a series of experiments. Addition of the caspase-1 inhibitor YVAD-CHO partially improved survival of infected wild-type macrophages, suggesting a coexistence of necroptosis and caspase-1-associated pyroptosis.
The main approaches of this study are outlined in Figure 1 . There is an obvious discrepancy in the in vivo and in vitro data from Rip3 2/2 mice, which did not show substantial differences in survival relative to wild-type mice, but Ifnar1 2/2 mice survived an extra 30-60 days. However, macrophages from Rip3 2/2 mice behaved like those from Ifnar1 2/2 mice: they resisted necroptosis in vitro, and enhanced control of S. Typhimurium in vivo when transferred into wild-type hosts. It may be important to address this discrepancy and identify the underlying mechanisms. It would be interesting to know whether other intracellular bacteria, such as Mycobacterium tuberculosis and Legionella pneumophila, also use the necroptosis pathway to kill macrophages, and thus escape innate immune defenses.
Taken together, the above findings add a novel pathway, necroptosis, to the list of pathways by which S. Typhimurium kills macrophages. Multiple pathways of cell death exist simultaneously in macrophages exposed to S. Typhimurium, where a complex interplay between apoptosis, autophagy, necroptosis and pyroptosis has been observed. Inhibition of a dominant molecule for a pathway may lead to a different type of cell death. As described above, for example, IFN-a/IFNb-induced necroptosis depends on inhibition of apoptotic caspase-8, either by intracellular infection with S. Typhimurium, or by adding the specific caspase inhibitor Z-VAD-fmk. The death receptors related to the TNF family can trigger apoptosis, but when apoptosis is blocked, they trigger necroptosis.
12,13
Salmonella infection of caspase-1-deficient macrophages bypasses pyroptosis, but results in an autophagic cell death. 3, 5 In L929 cells, knockdown of autophagy-related genes such as Atg-6 (beclin-1) and Atg-7 also inhibits necroptosis. 20 During infection, apoptotic and autophagic cells are removed quietly so that other tissues are less impaired by inflammation. Necroptotic and pytoptotic cells can trigger an inflammatory response that can help the Table 1 Comparison of four major pathways of programmed cell death organism to eliminate the pathogen. A range of cell death pathways is needed to orchestrate the protective and homeostatic functions of the immune system, with important questions remaining concerning which pathway will predominate and what the switch is. In infections caused by intracellular bacteria, further research is needed to define the biological and immunological significance of these different pathways, and their contribution to pathogenesis.
